Cross-cancer Prediction: A Novel Machine Learning Approach to Discover Molecular Targets for Development of Treatments for Multiple Cancers

Conventional cancer drug development has long been limited to organ- or tissue-specific cancer types. However, it has become increasingly known that specific genetic abnormalities are responsible for the carcinogenesis of multiple cancers. The recent US Food and Drug Administration (FDA) approval of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Katie, Wang, Dayong, Huang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198390/
https://www.ncbi.nlm.nih.gov/pubmed/30364884
http://dx.doi.org/10.1177/1176935118805398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198390/
https://www.ncbi.nlm.nih.gov/pubmed/30364884
http://dx.doi.org/10.1177/1176935118805398

Ejemplares similares